Validity and Reliability of the 6-Minute Pegboard and Ring Test (6PBRT) in Adults With Obstructive Sleep Apnea Syndrome

March 6, 2026 updated by: Engin Ramazanoglu, Mardin Artuklu University

Validity and Reliability of the 6-Minute Pegboard and Ring Test (6PBRT) in Adults With Obstructive Sleep Apnea: A Polysomnography-Based Methodological Study

Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder characterized by recurrent upper airway obstruction during sleep, leading to intermittent hypoxia and sleep fragmentation. In addition to its well-known cardiometabolic consequences, OSA may negatively affect functional capacity and daily activity performance. However, upper extremity functional capacity in individuals with OSA has not been adequately evaluated.

The 6-Minute Pegboard and Ring Test (6PBRT) is a functional test designed to assess upper extremity functional capacity during unsupported arm activity. Although the test has been widely used in respiratory diseases, its measurement properties have not yet been evaluated in patients with OSA.

The aim of this study is to investigate the validity and reliability of the 6PBRT in adults diagnosed with obstructive sleep apnea using polysomnography. Participants with OSA will undergo polysomnographic evaluation and complete the 6PBRT. Test-retest reliability will be assessed by repeating the test under the same conditions. The relationship between 6PBRT performance and polysomnographic parameters (AHI, ODI, minimum SpO₂ and T90) will also be examined. In addition, associations between 6PBRT performance and clinical scales such as the Epworth Sleepiness Scale and Functional Outcomes of Sleep Questionnaire will be analyzed.

The findings of this study are expected to provide evidence regarding the measurement properties of the 6PBRT in individuals with OSA and contribute to the clinical assessment of upper extremity functional capacity in this population.

Study Overview

Status

Not yet recruiting

Detailed Description

Obstructive sleep apnea (OSA) is characterized by repetitive episodes of upper airway obstruction during sleep resulting in intermittent hypoxia, sleep fragmentation, and increased sympathetic activity. These physiological disturbances may negatively affect physical performance, daily functioning, and exercise tolerance. Although previous studies have investigated balance, gait, and overall physical performance in individuals with OSA, upper extremity functional capacity has received limited attention.

The 6-Minute Pegboard and Ring Test (6PBRT) is a functional performance test that evaluates upper extremity endurance during unsupported arm activity. The test has been used primarily in patients with chronic respiratory diseases to assess functional limitation during activities involving arm elevation. However, the validity and reliability of the 6PBRT have not been investigated in individuals with OSA.

This observational methodological study aims to evaluate the validity and reliability of the 6PBRT in adults diagnosed with OSA using polysomnography. Participants diagnosed with OSA will be recruited from the sleep center of Mardin Training and Research Hospital. Demographic and clinical data including age, sex, body mass index, and comorbidities will be recorded. Polysomnographic parameters including apnea-hypopnea index (AHI), oxygen desaturation index (ODI), minimum oxygen saturation (SpO₂), and the percentage of sleep time with oxygen saturation below 90% (T90) will be collected from medical records.

Upper extremity functional capacity will be assessed using the 6PBRT. Participants will perform the test according to standardized procedures. Test-retest reliability will be evaluated by repeating the test under similar conditions. In addition, clinical scales including the Epworth Sleepiness Scale (ESS) and the Functional Outcomes of Sleep Questionnaire (FOSQ) will be administered.

The validity of the 6PBRT will be investigated by examining its relationship with polysomnographic parameters and clinical scales. Reliability will be evaluated using test-retest analysis and intraclass correlation coefficients. The results of this study will provide important information regarding the measurement properties of the 6PBRT in individuals with OSA and may support its use as a practical tool for assessing upper extremity functional capacity in clinical practice.

Study Type

Observational

Enrollment (Estimated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Mardin
      • Mardin, Mardin, Turkey (Türkiye), 47510
        • Mardin Artuklu University
        • Contact:
          • Funda Mete Cavus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adults diagnosed with obstructive sleep apnea based on polysomnography who are followed in the Sleep Center of Mardin Training and Research Hospital will be included in the study. Participants will be classified into mild, moderate, and severe obstructive sleep apnea groups according to the apnea-hypopnea index (AHI). In addition, age- and sex-matched healthy individuals without obstructive sleep apnea will be recruited as a control group.

Description

Inclusion Criteria:

  • Being between 18 and 65 years of age

Having a diagnosis of obstructive sleep apnea (OSA) confirmed by polysomnography

Having sufficient cognitive ability to understand and follow the test instructions

Having adequate shoulder range of motion to elevate the upper extremities above head level for performing the 6PBRT

Voluntarily agreeing to participate in the study and providing written informed consent

Exclusion Criteria:

  • Presence of neurological diseases that may significantly affect upper extremity function (e.g., stroke, multiple sclerosis, peripheral neuropathy)

Severe orthopedic conditions limiting upper extremity movement (e.g., advanced shoulder pathology, recent surgery, severe contracture)

Unstable cardiopulmonary conditions (e.g., recent myocardial infarction, decompensated heart failure, uncontrolled arrhythmia, acute COPD/asthma exacerbation)

Acute infection, febrile illness, or severe clinical exacerbation within the last 4 weeks

Pain severe enough to interfere with the test or any clinical condition preventing the safe administration of the test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Mild Obstructive Sleep Apnea
Adults diagnosed with mild obstructive sleep apnea based on polysomnography (Apnea-Hypopnea Index 5-14 events/hour). Participants will undergo assessment of upper extremity functional capacity using the 6-Minute Pegboard and Ring Test (6PBRT).
Moderate Obstructive Sleep Apnea
Adults diagnosed with moderate obstructive sleep apnea according to polysomnography findings (Apnea-Hypopnea Index 15-29 events/hour). Participants will perform the 6-Minute Pegboard and Ring Test to assess upper extremity functional capacity.
Severe Obstructive Sleep Apnea
Adults diagnosed with severe obstructive sleep apnea based on polysomnography (Apnea-Hypopnea Index ≥30 events/hour). Upper extremity functional capacity will be evaluated using the 6-Minute Pegboard and Ring Test.
Healthy Control
Age- and sex-matched healthy individuals without a diagnosis of obstructive sleep apnea. Participants will undergo assessment of upper extremity functional capacity using the 6-Minute Pegboard and Ring Test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-Minute Pegboard and Ring Test (6PBRT) Score
Time Frame: Baseline
Upper extremity functional capacity assessed using the 6-Minute Pegboard and Ring Test. The outcome will be the total number of rings moved during the 6-minute test.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test-Retest Reliability of the 6PBRT
Time Frame: Within 7 days
Reliability of the 6PBRT will be evaluated by repeating the test under the same conditions and calculating intraclass correlation coefficients.
Within 7 days
Hand Grip Strength
Time Frame: Baseline
Hand grip strength will be measured using a hand dynamometer to evaluate upper extremity muscle strength.
Baseline
Functional Outcomes of Sleep Questionnaire (FOSQ)
Time Frame: Baseline
Sleep-related functional status will be assessed using the Functional Outcomes of Sleep Questionnaire.
Baseline
Epworth Sleepiness Scale (ESS)
Time Frame: Baseline
Daytime sleepiness will be assessed using the Epworth Sleepiness Scale (score range 0-24).
Baseline
Polysomnography Parameters
Time Frame: Baseline
Relationship between 6PBRT performance and polysomnographic parameters including Apnea-Hypopnea Index (AHI), Oxygen Desaturation Index (ODI), minimum oxygen saturation (SpO₂), and percentage of sleep time with oxygen saturation below 90% (T90).
Baseline
Fatigue Severity Scale (FSS)
Time Frame: Baseline
Fatigue severity will be assessed using the Fatigue Severity Scale (score range 1-7). Higher scores indicate greater fatigue severity.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 23, 2026

Primary Completion (Estimated)

September 29, 2026

Study Completion (Estimated)

November 15, 2026

Study Registration Dates

First Submitted

March 6, 2026

First Submitted That Met QC Criteria

March 6, 2026

First Posted (Actual)

March 12, 2026

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 6, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data collected during the study will not be publicly shared to protect participant confidentiality. Only aggregated and anonymized results will be reported in scientific publications.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstructive Sleep Apnea

Subscribe